BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• 

  Bladder cancer

  Protara, CG Oncology Tout Promising Bladder Cancer Outcomes

  Protara is advancing a cell therapy that triggers both adaptive and innate antitumor immune responses, while CG Oncology’s approach makes use of an oncolytic immunotherapy that preferentially targets cancer cells and proliferates inside them, destroying them from the inside.

  December 6, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Lilly Pumps $3B Into Wisconsin Site as Compounders Close In on Tirzepatide

  Eli Lilly is aggressively ramping up its manufacturing capacity for tirzepatide as compounding pharmacies continue to challenge an FDA decision to formally end the shortage of the obesity and diabetes drug.

  December 6, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Amgen to Add 370 New Jobs in North Carolina With $1B Manufacturing Investment

  It is not clear what specifically the new facility will produce, though Amgen could be ramping up its manufacturing capacity as it prepares to enter the obesity space with MariTide.

  December 6, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  FDA Outlines Accelerated Review Guidelines in Waning Days of Biden Administration

  The program has recently become controversial as a number of high-profile advanced approvals were granted only for the drugs to fail a confirmatory trial later on. Now, the FDA has clearly laid out expectations.

  December 6, 2024

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Theralase(R) Launches New Clinical Study Site in Canada

  December 6, 2024

   · 

  9 min read
• Press Releases

  Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease

  December 6, 2024

   · 

  3 min read
• Press Releases

  Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

  December 6, 2024

   · 

  11 min read
• Press Releases

  Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

  December 6, 2024

   · 

  7 min read
• Press Releases

  Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

  December 6, 2024

   · 

  6 min read
• Press Releases

  Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting

  December 6, 2024

   · 

  9 min read